Inventor
LOUIS PICKER
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
C12NMicroorganisms or enzymes23%
Y02ATechnologies for adaptation to climate change10%
PatentTitleYear
12,442,018Recombinant cytomegalovirus vectors as vaccines for tuberculosis202511,834,669Recombinant cytomegalovirus vectors as vaccines for tuberculosis202311,692,012Human cytomegalovirus comprising exogenous antigens202311,628,215HIV vaccines comprising one or more population episensus antigens202311,554,168HIV vaccines comprising one or more population episensus antigens202311,305,015Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules202211,266,732Recombinant HCMV and RHCMV vectors and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to UNIV OREGON HEALTH & SCIENCE (7)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to INT AIDS VACCINE INITIATIVE INC (2)· patent assignee history
2023Patents assigned to TRIAD NAT SECURITY LLC (2)· patent assignee history
2023Patents assigned to VIR BIOTECHNOLOGY INC (2)· patent assignee history
2025Patents assigned to INT AIDS VACCINE INITITATIVE INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV OREGON HEALTH & SCIENCE | 7 | 2022–2025 |
| INT AIDS VACCINE INITIATIVE INC | 2 | 2023–2025 |
| TRIAD NAT SECURITY LLC | 2 | 2023 |
| VIR BIOTECHNOLOGY INC | 2 | 2023 |
| INT AIDS VACCINE INITITATIVE INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |